Tachyphylaxis, also known as acute tolerance, is a phenomenon characterized by a swift and temporary decrease in the response to a drug following its rapid or repeated administration. Unlike traditional tolerance, which develops over time with prolonged drug use, tachyphylaxis occurs rapidly within a short period, often within the same administration or over a few consecutive administrations.

Key Features of Tachyphylaxis

1. Temporal Pattern

Tachyphylaxis manifests as a quick reduction in the drug’s effectiveness, often after the initial dose or a few consecutive doses.

2. Short Duration

Tachyphylaxis is typically short-lived, and the diminished response may be reversible with a brief period of drug abstinence.

3. Recovery Period

The response to the drug may recover partially or fully after a temporary withdrawal period, distinguishing tachyphylaxis from more persistent forms of tolerance.

4. Various Factors

Factors contributing to tachyphylaxis can include receptor desensitization, depletion of relevant signalling molecules, or adaptive changes in the target tissue.

Mechanisms of Tachyphylaxis

1. Receptor Desensitization

Rapid or repeated stimulation of receptors can lead to a temporary reduction in their responsiveness, known as desensitization. This can occur due to changes in receptor conformation or alterations in signalling pathways.

2. Neurotransmitter Depletion

Some drugs act by releasing neurotransmitters. Rapid depletion of these neurotransmitters may contribute to tachyphylaxis.

3. Downregulation of Receptors

Continuous receptor activation can trigger the downregulation of receptors, reducing their abundance on the cell surface and diminishing the drug response.

4. Feedback Mechanisms

Feedback mechanisms within cells or tissues may be activated in response to prolonged or intense stimulation, leading to a reduction in drug effectiveness.

Examples of Tachyphylaxis

1. Nitroglycerin in Angina Treatment

Nitroglycerin, used to treat angina (chest pain), can exhibit tachyphylaxis. Repeated administration within a short time may lead to a reduced anti-anginal effect, necessitating dosage adjustments.

2. Bronchodilators in Asthma

Some bronchodilators used in the treatment of asthma may show tachyphylaxis. Repeated use within a short period may result in a diminished bronchodilatory response.

3. Vasodilators in Blood Pressure Control

Certain vasodilators used to control blood pressure may exhibit tachyphylaxis. Rapid tolerance can occur with repetitive administration, requiring dosage modification.